Company CVAbout Parnax Lab Ltd 
Parnax Lab Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company.
Company Coordinates
Company Details
Gala 114 Bldg No 8, Jogani Ind Complex Chunabhatti Mumbai Maharashtra : 400022
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 11.49 Cr
Number of Shares
1.15 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
01-Jul-2022
1.15
11.49
1670750
10
Conversion of Warrants
30-Mar-2022
98.15
9.81
1310000
10
Conversion of Warrants
12-Jan-2012
85.05
8.50
5304866
10
Amalgamation
12-Jan-2012
85.05
8.50
5304866
10
Amalgamation
08-Apr-2010
32
3.20
2800000
10
Allotment of Equity To Others
08-Apr-2010
32
3.20
2800000
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
9.4112
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Binoy Baiju Shah (11.92%)
Highest Public shareholder
Suman Gupta (1.62%)
Individual Investors Holdings
24.93%
Board of Directors
Management
Designation
Remuneration
Vindyak B Desai
Independent Director
0
Prakash M Shah
Director & Chief Executive Off
54.0 lacs
Baiju M Shah
Managing Director & CFO
54.0 lacs
Ami M Shah
Director
0
T V Anantharaman
Independent Director
0
Yogesh Varia
Independent Director
0
Preet Vijay Kukreja
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Packing Materials
0.0087
0%
Packing Materials
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
63 Cr
(Quarterly Results - Sep 2025)
Net Profit:
4 Cr
Pharmaceuticals & Biotechnology
INR 137 Cr (Micro Cap)
12.00
29
0.00%
0.77
12.26%
1.53
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
